Profile of Cerebrospinal microRNAs in Fibromyalgia

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Bjersing, Jan L ^a   Lundborg, Christopher ^b   Bokarewa, Maria I ^a   Mannerkorpi, Kaisa ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA ACADEMY AT UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 125B 5P; MICRORNA 145 5P; MICRORNA 195 5P; MICRORNA 21 5P; MICRORNA 223 3P; MICRORNA 23A 3P; MICRORNA 23B 3P; MICRORNA 29A 3P; MICRORNA 99B 5P; UNCLASSIFIED DRUG;

ADULT; ALGOMETRY; ARTICLE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FATIGUE; FEMALE; FIBROMYALGIA; FIBROMYALGIA IMPACT QUESTIONNAIRE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; MULTIDIMENSIONAL FATIGUE INVENTORY; PAIN; PAIN THRESHOLD; QUANTITATIVE ANALYSIS; RATING SCALE; REAL TIME POLYMERASE CHAIN REACTION;

CASE-CONTROL STUDIES; FATIGUE; FEMALE; FIBROMYALGIA; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MICRORNAS; MIDDLE AGED; PAIN; TRANSCRIPTOME;

EID: 84886385528     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078762     Document Type: Article

References (50)

1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, et al. (1990) The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33: 160-172. doi:10.1002/art.1780330203. PubMed: 2306288.
2. Bennett RM, (2002) Adult growth hormone deficiency in patients with fibromyalgia. Curr Rheumatol Rep 4: 306-312. doi:10.1007/s11926-002-0039-4. PubMed: 12126582.
3. Bennett RM, Cook DM, Clark SR, Burckhardt CS, Campbell SM, (1997) Hypothalamic-pituitary-insulin-like growth factor-I axis dysfunction in patients with fibromyalgia. J Rheumatol 24: 1384-1389. PubMed: 9228141.
4. Bjersing JL, Dehlin M, Erlandsson M, Bokarewa MI, Mannerkorpi K, (2012) Changes in pain and insulin-like growth factor 1 in fibromyalgia during exercise: the involvement of cerebrospinal inflammatory factors and neuropeptides. Arthritis Res Ther 14: R162. doi:10.1186/ar3902. PubMed: 22776095.
5. Aaron LA, Burke MM, Buchwald D, (2000) Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern Med 160: 221-227. doi:10.1001/archinte.160.2.221. PubMed: 10647761.
6. Mease PJ, Clauw DJ, Christensen R, Crofford LJ, Gendreau RM, et al. (2011) Toward development of a fibromyalgia responder index and disease activity score: OMERACT module update. J Rheumatol 38: 1487-1495. doi:10.3899/jrheum.110277. PubMed: 21724721.
7. Staud R, (2012) Peripheral and central mechanisms of fatigue in inflammatory and noninflammatory rheumatic diseases. Curr Rheumatol Rep 14: 539-548. doi:10.1007/s11926-012-0277-z. PubMed: 22802155.
8. Arnold LM, Hudson JI, Hess EV, Ware AE, Fritz DA, et al. (2004) Family study of fibromyalgia. Arthritis Rheum 50: 944-952. doi:10.1002/art.20042. PubMed: 15022338.
9. Markkula R, Järvinen P, Leino-Arjas P, Koskenvuo M, Kalso E, et al. (2009) Clustering of symptoms associated with fibromyalgia in a Finnish Twin Cohort. Eur J Pain 13(7):: 744-750. doi:10.1016/j.ejpain.2008.09.007. PubMed: 18938094.
10. Lee YH, Choi SJ, Ji JD, Song GG, (2012) Candidate gene studies of fibromyalgia: a systematic review and meta-analysis. Rheumatol Int 32(2):: 417-426. doi:10.1007/s00296-010-1678-9. PubMed: 21120487.
11. Smith SB, Maixner DW, Fillingim RB, Slade G, Gracely RH, et al. (2012) Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgia. Arthritis Rheum 64: 584-593. doi:10.1002/art.33338. PubMed: 21905019.
12. Denk F, McMahon SB, (2012) Chronic pain: emerging evidence for the involvement of epigenetics. Neuron 73: 435-444. doi:10.1016/j.neuron.2012.01.012. PubMed: 22325197.
13. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20. doi:10.1016/j.cell.2004.12.035. PubMed: 15652477.
14. Baek D, Villén J, Shin C, Camargo FD, Gygi SP, et al. (2008) The impact of microRNAs on protein output. Nature 455: 64-71. doi:10.1038/nature07242. PubMed: 18668037.
15. Zhu H, Fan GC, (2011) Extracellular/circulating microRNAs and their potential role in cardiovascular disease. Am J Cardiovascular Dis 1: 138-149. PubMed: 22059153.
16. Meza-Sosa KF, Valle-García D, Pedraza-Alva G, Pérez-Martínez L, (2012) Role of microRNAs in central nervous system development and pathology. J Neurosci Res 90: 1-12. doi:10.1002/jnr.22701. PubMed: 21922512.
17. Schouten M, Aschrafi A, Bielefeld P, Doxakis E, Fitzsimons CP, (2013) microRNAs and the regulation of neuronal plasticity under stress conditions. Neuroscience 241C: 188-205. PubMed: 23500144.
18. Mannerkorpi K, Nordeman L, Cider A, Jonsson G, (2010) Does moderate-to-high intensity Nordic walking improve functional capacity and pain in fibromyalgia? A prospective randomized controlled trial. Arthritis Res Ther 12: R189. doi:10.1186/ar3159. PubMed: 20942911.
19. Kosek E, Ekholm J, Nordemar R, (1993) A comparison of pressure pain thresholds in different tissues and body regions. Long-term reliability of pressure algometry in healthy volunteers. Scand J Rehabil Med 25: 117-124. PubMed: 8248762.
20. Burckhardt CS, Clark SR, Bennett RM, (1991) The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18: 728-733. PubMed: 1865419.
21. Ericsson A, Mannerkorpi K, (2007) Assessment of fatigue in patients with fibromyalgia and chronic widespread pain. Reliability and validity of the Swedish version of the MFI-20. Disabil Rehabil 29: 1665-1670. doi:10.1080/09638280601055782. PubMed: 17852297.
22. Jensen SG, Lamy P, Rasmussen MH, Ostenfeld MS, Dyrskjøt L, et al. (2011) Evaluation of two commercial global miRNA expression profiling platforms for detection of less abundant miRNAs. BMC Genomics 12: 435. doi:10.1186/1471-2164-12-435. PubMed: 21867561.
23. Qiu X, Wu H, Hu R, (2013) The impact of quantile and rank normalization procedures on the testing power of gene differential expression analysis. BMC Bioinformatics 14: 124. doi:10.1186/1471-2105-14-124. PubMed: 23578321.
24. Bhalala OG, Pan L, Sahni V, McGuire TL, Gruner K, et al. (2012) microRNA-21 regulates astrocytic response following spinal cord injury. J Neurosci Off J Soc Neurosci 32(50):: 17935-17947. doi:10.1523/JNEUROSCI.3860-12.2012. PubMed: 23238710.
25. Zhang L, Dong LY, Li YJ, Hong Z, Wei WS, (2012) miR-21 represses FasL in microglia and protects against microglia-mediated neuronal cell death following hypoxia/ischemia. Glia 60: 1888-1895. doi:10.1002/glia.22404. PubMed: 22907769.
26. Strickland IT, Richards L, Holmes FE, Wynick D, Uney JB, et al. (2011) Axotomy-induced miR-21 promotes axon growth in adult dorsal root ganglion neurons. PLOS ONE 6: e23423. doi:10.1371/journal.pone.0023423. PubMed: 21853131.
27. Buller B, Liu X, Wang X, Zhang RL, Zhang L, et al. (2010) MicroRNA-21 protects neurons from ischemic death. FEBS J 277: 4299-4307. doi:10.1111/j.1742-4658.2010.07818.x. PubMed: 20840605.
28. Shi Y, Zhang X, Tang X, Wang P, Wang H, et al. (2012) MiR-21 is continually elevated long-term in the brain after exposure to ionizing radiation. Radiat Res 177: 124-128. doi:10.1667/RR2764.1. PubMed: 22034847.
29. Sachdeva M, Mo YY, (2010) miR-145-mediated suppression of cell growth, invasion and metastasis. Am J Transl Res 2: 170-180. PubMed: 20407606.
30. Law PT, Ching AK, Chan AW, Wong QW, Wong CK, et al. (2012) MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma. Carcinogenesis 33: 1134-1141. doi:10.1093/carcin/bgs130. PubMed: 22431718.
31. Wang WT, Zhao YN, Han BW, Hong SJ, Chen YQ, (2013) Circulating microRNAs identified in a genome-wide serum microRNA expression analysis as noninvasive biomarkers for endometriosis. J Clin Endocrinol Metab 98: 281-289. doi:10.1210/jc.2012-2415. PubMed: 23118427.
32. Pekow JR, Dougherty U, Mustafi R, Zhu H, Kocherginsky M, et al. (2012) miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes. Inflamm Bowel Dis 18: 94-100. doi:10.1097/00054725-201212001-00232. PubMed: 21557394.
33. Zucchi FC, Yao Y, Ward ID, Ilnytskyy Y, Olson DM, et al. (2013) Maternal stress induces epigenetic signatures of psychiatric and neurological diseases in the offspring. PLOS ONE 8: e56967. doi:10.1371/journal.pone.0056967. PubMed: 23451123.
34. Ugalde AP, Ramsay AJ, de la Rosa J, Varela I, Mariño G, et al. (2011) Aging and chronic DNA damage response activate a regulatory pathway involving miR-29 and p53. EMBO J 30: 2219-2232. doi:10.1038/emboj.2011.124. PubMed: 21522133.
35. Martinez I, Cazalla D, Almstead LL, Steitz JA, DiMaio D, (2011) miR-29 and miR-30 regulate B-Myb expression during cellular senescence. Proc Natl Acad Sci U S A 108: 522-527. doi:10.1073/pnas.1017346108. PubMed: 21187425.
36. Shioya M, Obayashi S, Tabunoki H, Arima K, Saito Y, et al. (2010) Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3. Neuropathol Appl Neurobiol 36: 320-330. doi:10.1111/j.1365-2990.2010.01076.x. PubMed: 20202123.
37. Margis R, Margis R, Rieder CR, (2011) Identification of blood microRNAs associated to Parkinsonis disease. J Biotechnol 152: 96-101. doi:10.1016/j.jbiotec.2011.01.023. PubMed: 21295623.
38. Perbellini R, Greco S, Sarra-Ferraris G, Cardani R, Capogrossi MC, et al. (2011) Dysregulation and cellular mislocalization of specific miRNAs in myotonic dystrophy type 1. Neuromuscul Disord NMD 21: 81-88. doi:10.1016/j.nmd.2010.11.012. PubMed: 21169019.
39. Ohlsson Teague EM, Van der Hoek KH, Van der Hoek MB, Perry N, Wagaarachchi P, et al. (2009) MicroRNA-regulated pathways associated with endometriosis. Mol Endocrinol 23: 265-275. PubMed: 19074548.
40. Soci UP, Fernandes T, Hashimoto NY, Mota GF, Amadeu MA, et al. (2011) MicroRNAs 29 are involved in the improvement of ventricular compliance promoted by aerobic exercise training in rats. Physiol Genomics 43: 665-673. doi:10.1152/physiolgenomics.00145.2010. PubMed: 21447748.
41. Rodriguez RE, (2012) Morphine and microRNA Activity: Is There a Relation with Addiction? Front Genet 3: 223. PubMed: 23162566.
42. Zhu S, Pan W, Song X, Liu Y, Shao X, et al. (2012) The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-alpha. Nature medicine 18: 1077-1086.
43. Fei X, Qi M, Wu B, Song Y, Wang Y, et al. (2012) MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression. FEBS Lett 586: 392-397. doi:10.1016/j.febslet.2012.01.006. PubMed: 22265971.
44. van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, et al. (2006) A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A 103: 18255-18260. doi:10.1073/pnas.0608791103. PubMed: 17108080.
45. Hui W, Yuntao L, Lun L, WenSheng L, ChaoFeng L, et al. (2013) MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1. PLOS ONE 8: e54932. doi:10.1371/journal.pone.0054932. PubMed: 23383003.
46. Mellios N, Huang HS, Grigorenko A, Rogaev E, Akbarian S, (2008) A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex. Hum Mol Genet, 17(19):: 3030-3042. doi:10.1093/hmg/ddn201. PubMed: 18632683.
47. Ai J, Sun LH, Che H, Zhang R, Zhang TZ, et al. (2013) MicroRNA-195 protects against dementia induced by chronic brain hypoperfusion via its anti-amyloidogenic effect in rats. J Neurosci Off J Soc Neurosci 33: 3989-4001. doi:10.1523/JNEUROSCI.1997-12.2013. PubMed: 23447608.
48. Zhu HC, Wang LM, Wang M, Song B, Tan S, et al. (2012) MicroRNA-195 downregulates Alzheimer's disease amyloid-beta production by targeting BACE1. Brain research bulletin 88:596-601.
49. Harraz MM, Eacker SM, Wang X, Dawson TM, Dawson VL, (2012) MicroRNA-223 is neuroprotective by targeting glutamate receptors. Proc Natl Acad Sci U S A 109: 18962-18967. doi:10.1073/pnas.1121288109. PubMed: 23112146.
50. Poh KW, Yeo JF, Ong WY, (2011) MicroRNA changes in the mouse prefrontal cortex after inflammatory pain. Eur J Pain 15801:: e801-e812. PubMed: 21397537.